Skip to main content

Treatment.com’s Innovative Healthcare AI is Put to the Test by Doctors

Written by Customer Service on . Posted in Public Companies.

VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) — Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE) is a healthcare technology company that has developed an exclusive AI software to think like a doctor. Using the latest artificial intelligence and machine learning, paired with a global team of doctors, Treatment has created an engine that can assess symptoms and provide a probable diagnosis with the same reasoning approach as a trained doctor.

Treatment.com is founded by John Fraser, a computer scientist and entrepreneur with a background in healthcare technology, and Dr. Kevin Peterson, a leading doctor and tenured professor at the University of Minnesota Medical School. Together, their combined expertise has brought the latest in modern technology to the Western medical field with the mission to make healthcare information more accessible and improve healthcare around the globe. The Treatment AI engine will be leveraged to support consumer healthcare decisions, and integrated into the medical industry to improve costs and efficiencies of care.

“In developing this technology, we knew we had to build it from the ground up, in the exact way that doctors are taught in medical school. We built out a team of leading doctors, and we tested our AI in a real medical setting in a busy medical clinic and also with a leading medical school. The doctors vetted the results including the accuracy and efficiency of the patient on-boarding; our AI tool made their visits more effective and improved overall care,” says CEO, John Fraser.

“The ability to process thousands of data points and analyze a patient’s symptoms is a significant achievement for the medical community. This tool uses a patient’s unique medical profile to better understand the probability of a diagnosis and to suggest the best next steps. Our AI can act as a powerful tool for health care professionals and medical schools to test diagnoses and to provide the doctor with a detailed medical history that makes each visit more informed and accurate,” said Chief Medical Officer Kevin Peterson.

Treatment.com will be launching its first product, a consumer mobile app called Cara this summer.

About Treatment.com

Treatment.com is a disruptive healthcare technology company that is harnessing the power of AI to help Canadians improve their health through personalized recommendations and insights. Based in Vancouver, the company spent the last five years working with a team of world-class doctors, engineers, mathematicians, and AI specialists to develop a complex AI engine that leverages the most robust, personalized data to generate highly predictive and accurate insights. Treatment.com is the parent company of Cara. This summer, Cara will be empowering Canadians to take control of their health with the launch of an innovative mobile app powered by this exclusive AI engine.

For more investor information on Treatment.com, please visit https://treatment.com/investors/.

On behalf of the Board of Directors,

“John Fraser”                        

John Fraser, Chief Executive Officer

Forward Looking Statement

This news release contains forward-looking statements relating to the future operations of Treatment.com, International, Inc. (Treatment) and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should” “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Treatment, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment’s expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.

The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.

For more information:

Investor Contact: investors@treatment.com    1 (888) 788-8955

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.